Global Salesforce SELA Consolidation for Multi-Region Healthcare Organisation

Challenge

The global healthcare organisation operated with a fragmented Salesforce licensing model spanning nine separate regional contracts managed independently across North America, Europe, APAC, and other regions. Each regional team had negotiated independently, resulting in inconsistent pricing, licence terms, and implementation standards across the organisation. The organisation was facing renewal across all nine agreements simultaneously.

When Salesforce proposed consolidation into a unified global Standard Enterprise License Agreement (SELA), the proposal created a new set of problems:

• Pricing misalignment: The proposed SELA pricing was 29% above the combined cost of the existing regional contracts, despite supposedly delivering consolidation benefits
• Licence over-provisioning: Procurement had over-licensed Health Cloud during COVID-19 expansion. Analysis revealed 180 Health Cloud licences (28% of the estate) were completely unused and generating no ROI
• Hyperforce pricing errors: Regional teams in the EU had been incorrectly charged Hyperforce EU tier pricing for standard instances, representing material overpayment relative to actual infrastructure requirements
• MuleSoft inefficiency: Integration licensing was fragmented and over-provisioned across regions without consolidated governance
• Data residency complexity: Multiple regional requirements (GDPR, Swiss data protection, regional healthcare regulations) created procurement obstacles in SELA discussions

Approach

Redress engaged at the beginning of the regional renewal cycle, providing nine months to execute a comprehensive consolidation strategy before lock-in occurred. Our engagement combined licence optimisation, pricing forensics, and regulatory intelligence.

Phase 1: Cross-Regional Licence Audit — We conducted detailed usage analysis across all nine regional instances, identifying 180 Health Cloud licences with zero activity over 12 months. This represented approximately $420,000 in annual waste on a platform that was never deployed. We also identified significant inconsistency in deployment methodologies across regions, with some teams overprovisioning by 35% while others were constrained.

Phase 2: Hyperforce Pricing Forensics — We analysed regional infrastructure assignments and discovered that EU instances had been incorrectly configured under Hyperforce EU tier pricing (which carries a 12-15% premium for data residency compliance) despite not requiring Hyperforce capabilities. Correcting this misclassification represented immediate savings without reducing functionality or compliance posture.

Phase 3: Competitive Benchmarking Against Oracle Health (Cerner) — To strengthen leverage in SELA negotiations, we developed a detailed business case for transitioning Health Cloud workflows to Oracle Health (Cerner), which was already deployed elsewhere in the healthcare industry. This provided a credible competitive alternative that specifically threatened Salesforce's Health Cloud revenue stream, driving material rate improvements.

Phase 4: SELA Restructuring with Regional Sub-Agreements — Rather than accepting Salesforce's proposed flat global SELA structure, we negotiated a hybrid approach: a global SELA framework with regional sub-agreements that retained necessary data residency flexibility while consolidating volume leverage. This structure provided compliance certainty without price penalty.

Outcome

Key Takeaways

This engagement illustrates the complexity and risk of managing Salesforce across fragmented regional agreements, and the substantial opportunity present in consolidation if executed strategically.

Fragmentation always conceals pricing anomalies. When regional teams negotiate independently, inconsistent rates, misclassified infrastructure, and over-provisioned capacity accumulate invisibly. Consolidation creates the opportunity to surface and correct these inefficiencies, but only if conducted with forensic rigour before lock-in occurs.

SELA proposals are not automatically beneficial. Vendors propose SELAs to consolidate their own administrative burden, not to reduce customer costs. Without independent analysis, a SELA can actually increase customer costs by 20-30% while eliminating negotiating flexibility. The key is to use SELA consolidation as a vehicle for renegotiating rates down, not accepting vendor pricing as given.

Health Cloud is a strategic vulnerability for healthcare customers. Health Cloud carries premium pricing and is difficult to replace without significant operational disruption. This creates pricing power for Salesforce. However, introducing credible competitive alternatives (Oracle Health, Epic integration via Mulesoft) provides negotiating leverage that drives material rate improvements.

Hyperforce pricing mistakes are endemic. We encounter systematic overcharging for Hyperforce infrastructure across healthcare and financial services organisations. Regional teams often don't understand that standard instances already meet data residency requirements without Hyperforce. A simple classification audit can surface and correct these errors.

Early engagement enables comprehensive restructuring. This engagement succeeded because we engaged nine months before renewal, providing time for forensic analysis, competitive benchmarking, and iterative negotiation. Organisations that delay engagement until 60 days before renewal are forced to accept whatever SELA terms vendors offer.